1. AbbVie will release Q1 2025 results on April 25, 2025. 2. Live earnings call at 8 a.m. CST, accessible via Investor Relations site. 3. AbbVie focuses on innovative medicines addressing serious health issues. 4. Key therapeutic areas include immunology, oncology, and aesthetics. 5. Archived version of the results will be available later that day.
Upcoming earnings but lacks forward-looking projections or catalysts. Similar past earnings announcements had variable impacts.
Investors await earnings results, but overall impact on share price remains cautious.
Immediate impact expected around earnings announcement date; historical trends show strong market reactions.
-- AbbVie (NYSE: ABBV) will announce its first-quarter 2025 financial results on Friday, April 25, 2025, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter) and YouTube.
Investors:
Gabby Tarbert
Liz Shea
(224) 244-0111
(847) 935-2211
SOURCE AbbVie